Six years ago Abiraterone was hailed as a medical breakthrough that could offer men extra time with loved ones and a chance to delay chemotherapy and its debilitating side effects.
Today the body that recommends what can and cannot be paid for said it 'wasn't cost effective'.
Prostate cancer patients have now been told that the life-extending drug will not be routinely prescribed unless they have chemotherapy.
One man from North Yorkshire who is fighting prostate cancer is calling for a rethink:
More top news
Former Royal Marine Konstandinos Erik Scurfield from Barnsley has been killed while fighting against Islamic State militants in Syria.
Steve Bruce has been accused of trying to "defend the indefensible" over Maynor Figueroa's tackle on Stephen Ireland.
Former Leeds and Sheffield United midfielder Chris Kamara says that people are more willing to report racist incidents in sport.